ATLAS: A Phase II, open-label study of rucaparib in patients with locally advanced or metastatic urothelial carcinoma Meeting Abstract
| Authors: | Grivas, P.; Teo, M. Y.; Vogelzang, N.; Alva, A.; Zakharia, Y.; Adra, N.; Drakaki, A.; Hussain, A.; Morales-Barrera, R.; Necchi, A.; Rodriguez-Vida, A.; Feyerabend, S.; Gupta, S.; Josephs, D. H.; Loriot, Y.; Srinivas, S.; Wride, K.; Thomas, D.; Dusek, R.; Simmons, A. D.; Nepert, D.; Chowdhury, S. |
| Abstract Title: | ATLAS: A Phase II, open-label study of rucaparib in patients with locally advanced or metastatic urothelial carcinoma |
| Meeting Title: | 110th Annual Meeting of the American Association for Cancer Research (AACR) |
| Journal Title: | Cancer Research |
| Volume: | 79 |
| Issue: | 13 Suppl. |
| Meeting Dates: | 2019 Mar 29-Apr 3 |
| Meeting Location: | Atlanta, GA |
| ISSN: | 0008-5472 |
| Publisher: | American Association for Cancer Research |
| Date Published: | 2019-07-01 |
| Language: | English |
| ACCESSION: | WOS:000488129900161 |
| DOI: | 10.1158/1538-7445.Am2019-ct179 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: CT179 -- Source: Wos |
